These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 11588120)

  • 1. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
    Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
    Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
    Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
    Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans.
    Haynes WG; Ferro CJ; O'Kane KP; Somerville D; Lomax CC; Webb DJ
    Circulation; 1996 May; 93(10):1860-70. PubMed ID: 8635265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men.
    Strachan FE; Spratt JC; Wilkinson IB; Johnston NR; Gray GA; Webb DJ
    Hypertension; 1999 Jan; 33(1 Pt 2):581-5. PubMed ID: 9931169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
    Allcock GH; Warner TD; Vane JR
    Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men.
    Dhaun N; Strachan FE; Newby DE; Johnston NR; Ford NF; Hammett JL; Palmisano M; Webb DJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):611-22. PubMed ID: 16305585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ETB receptors limits the efficacy of nonselective endothelin antagonists in vivo.
    Allcock GH; Warner TD
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S177-9. PubMed ID: 8587355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-mediated vascular and metabolic actions of endothelin-1 in canine small intestine.
    King-VanVlack CE; Mewburn JD; Chapler CK
    Am J Physiol; 1999 May; 276(5):G1131-6. PubMed ID: 10330003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat.
    Bigaud M; Pelton JT
    Br J Pharmacol; 1992 Dec; 107(4):912-8. PubMed ID: 1467841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
    Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ
    Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men.
    Böhm F; Pernow J; Lindström J; Ahlborg G
    Clin Sci (Lond); 2003 Feb; 104(2):143-51. PubMed ID: 12546636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients.
    Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
    J Heart Lung Transplant; 2005 Jun; 24(6):665-70. PubMed ID: 15949725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
    Ferro CJ; Haynes WG; Hand MF; Webb DJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
    Ferro CJ; Spratt JC; Haynes WG; Webb DJ
    Circulation; 1998 Jun; 97(23):2323-30. PubMed ID: 9639376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ET-1-induced pulmonary vasoconstriction shifts from ET(A)- to ET(B)-receptor-mediated reaction after preconstriction.
    Schmeck J; Gluth H; Mihaljevic N; Born M; Wendel-Wellner M; Krafft P
    J Appl Physiol (1985); 1999 Dec; 87(6):2284-9. PubMed ID: 10601179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific endothelin ET(A) receptor antagonism does not modulate insulin-induced hemodynamic effects in the human kidney, eye, or forearm.
    Rab A; Dallinger S; Polak K; Pleiner J; Polska E; Wolzt M; Schmetterer L
    J Pharmacol Exp Ther; 2004 May; 309(2):692-6. PubMed ID: 14757848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary vasoconstriction by endothelin-1 in anesthetized goats: role of endothelin receptors, nitric oxide and prostanoids.
    García JL; Fernández N; García-Villalón AL; Monge L; Gómez B; Diéguez G
    Eur J Pharmacol; 1996 Nov; 315(2):179-86. PubMed ID: 8960882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.